E-LIB Suche - Ergebnisse für: Hsu, Benjamin

1

Feasibility of manufacture of chimeric antigen receptor-reg..:

Bastian, Hervé ; Lounnas-Mourey, Nadia ; Heimendinger, Pierre...
Translational Medicine Communications. 8 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

2

Computing Group-By and Aggregates on Massively Parallel Sys..:

, In: 2023 IEEE International Conference on Big Data (BigData),

Mou, Chengcheng ; Pham, Minh ; Hsu, Benjamin. - p. 149-158 , 2023

Link: https://doi.org/10.1109/..

3

Long-term safety and efficacy of sirukumab for patients wit..:

Aletaha, Daniel ; Bingham, Clifton O ; Karpouzas, George Athanasios...
RMD Open. 7 (2021) 1 - p. e001465 , 2021

Link: https://doi.org/10.1136/..

4

Frailty and Cause-Specific Hospitalizations in Community-Dw..:

Hsu, Benjamin ; Naganathan, V. ; Blyth, F.M....
The Journal of nutrition, health and aging. 24 (2020) 6 - p. 563-569 , 2020

Link: https://doi.org/10.1007/..

5

Effects of immunomodulatory drugs on depressive symptoms: A..:

MRC ImmunoPsychiatry Consortium ; Wittenberg, Gayle M. ; Stylianou, Annie...
Molecular Psychiatry. 25 (2019) 6 - p. 1275-1285 , 2019

Link: https://doi.org/10.1038/..

6

Efficacy and safety of sirukumab in Japanese patients with ..:

Tanaka, Yoshiya ; Takeuchi, Tsutomu ; Harigai, Masayoshi...
Modern Rheumatology. 29 (2018) 2 - p. 306-313 , 2018

Link: https://doi.org/10.1080/..

7

Joint longitudinal model development: application to exposu..:

Hu, Chuanpu ; Xu, Yan ; Zhuang, Yanli...
Journal of Pharmacokinetics and Pharmacodynamics. 45 (2018) 5 - p. 679-691 , 2018

Link: https://doi.org/10.1007/..

8

Investigating sirukumab for rheumatoid arthritis: 2-year re..:

Thorne, Carter ; Takeuchi, Tsutomu ; Karpouzas, George Athanasios...
RMD Open. 4 (2018) 2 - p. e000731 , 2018

Link: https://doi.org/10.1136/..

9

Confirmatory Population Pharmacokinetic Analysis for Siruku..:

Xu, Yan ; Hu, Chuanpu ; Zhuang, Yanli...
The Journal of Clinical Pharmacology. 58 (2018) 7 - p. 939-951 , 2018

Link: https://doi.org/10.1002/..

10

Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhi..:

van Vollenhoven, Ronald F ; Hahn, Bevra H ; Tsokos, George C...
The Lancet. 392 (2018) 10155 - p. 1330-1339 , 2018

Link: https://doi.org/10.1016/..

11

Exposure‐Response Modeling Analyses for Sirukumab, a Human ..:

Xu, Yan ; Hu, Chuanpu ; Zhuang, Yanli...
The Journal of Clinical Pharmacology. 58 (2018) 11 - p. 1501-1515 , 2018

Link: https://doi.org/10.1002/..

12

Sirukumab in rheumatoid arthritis refractory to sulfasalazi..:

Takeuchi, Tsutomu ; Yamanaka, Hisashi ; Harigai, Masayoshi...
Arthritis Research & Therapy. 20 (2018) 1 - p. , 2018

Link: https://doi.org/10.1186/..

13

The effects of interleukin-6 neutralizing antibodies on sym..:

Sun, Yu ; Wang, Dai ; Salvadore, Giacomo...
Brain, Behavior, and Immunity. 66 (2017) - p. 156-164 , 2017

Link: https://doi.org/10.1016/..

14

300. Improvement in Measures of Depressed Mood and Anhedoni..:

Sun, Yu ; Wittenberg, Gayle ; Chen, Guang...
Biological Psychiatry. 81 (2017) 10 - p. S123 , 2017

Link: https://doi.org/10.1016/..

15

A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled..:

Rovin, Brad H. ; van Vollenhoven, Ronald F. ; Aranow, Cynthia...
Arthritis & Rheumatology. 68 (2016) 9 - p. 2174-2183 , 2016

Link: https://doi.org/10.1002/..